Structural composition and clinical features of dermatological patients with keratinocytic skin tumors
pdf (Русский)

Keywords

basal cell skin cancer
basal cell skin carcinoma

How to Cite

Khasanov, R., Faizullina, E., Khismatulina, I., & Murtazin, A. (2022). Structural composition and clinical features of dermatological patients with keratinocytic skin tumors. Voprosy Onkologii, 67(1), 91–96. https://doi.org/10.37469/0507-3758-2021-67-1-91-96

Abstract

Basal cell skin cancer (BCС) is the most common malignancy that is found in dermatological practice. The purpose of the study: to determine the structure of clinical manifestations of BCС in ambulant dermatological patients. The study was conducted from 2015 to 2017 in a private clinic in Kazan, which has a license to provide medical care in the specialties "dermatovenerology" and "surgery". We studied the results of examination of 2730 patients with skin tumors available in outpatient cards. 101 patients with histologically verified BCС were examined, including 29% of men (n=29) and 71% of women (n=72), the average age was 59.7±14.9 years (median – 61.5 years). The percentage of patients with BCС among patients with all skin malignancies at the dermatological reception was 95.3% (n=101). Most often, patients aged 60-74 years suffered from BCС: women – in 21.0% (n=21) and men – in 16.0% (n=16), respectively. The proportion of women aged 45-59 years was significantly higher – 20.0%, than the proportion of men – 9.0% (p<0.05). Men were significantly more likely to see a dermatologist – 55.0% in less than a year from the onset of the disease, than women – 21.4% (p<0.01). The proportion of women (44.6%) who noted the appearance of a tumor over a long period (≥5 years) was significantly less than the proportion of men 15.0% (p<0.05). The most common variant of BCС was the nodular form n=77 (76.2%), in which the primary elements of 80.5% were identified by dermatologists as single 5-10 mm papules. The oculo-fronto-nasal region was involved in the pathological process in 47.5% (n=48) of cases, which is significantly more frequent than in other localisations (p<0.05). Dermatoscopy improved the visualization of the atypical vascular network.

https://doi.org/10.37469/0507-3758-2021-67-1-91-96
pdf (Русский)

References

Беляев А.М., Прохоров Г.Г., Раджабова З.А. и др. Пункционная криодеструкция рецидивных базалиом области лица с ультразвуковым сканированием и мониторингом операции. Вопросы онкологии. 2016; 62(2): 296-301 [Belyaev A.M., Prokhorov G.G., Radzhabova Z.A. et al. Puncture cryodestruction of recurrent facial area basaliomas with ultrasound scan and surgery monitoring. Voprosy Oncologii. 2016;62(2):296-301(In Russ.)].

Гамаюнов С.В., Шумская И.С. Базальноклеточный рак кожи — обзор современного состояния проблемы. Практическая онкология. 2012; 13(2): 92-106 [Gamayunov S.V., Shumskaya I.S. Basal cell carcinoma — overview of the current state of the problem. Prakticheskaya onkologiya. 2012;13(2):92-106 (In Russ.)].

Elder D.E., Massi D., Scolyer R.A. et al. WHO Classification of Skin Tumours. Lyon, France: IARC, 2018.

Злокачественные новообразования в России в 2017 году (заболеваемость и смертность) / под ред. КапринаА.Д., СтаринскогоВ.В., Петровой Г.В. М.: МНИОИ им. П.А. Герцена — филиал ФГБУ «НМИЦ радиологии» Минздрава России. 2018: 250 [Kaprin A.D., Starinskiy V.V., Petrova G.V., editors. Malignant neoplasms in Russia in 2017 (morbidity and mortality). Moscow: 2018:250 (In Russ.)].

Рак кожи базальноклеточный и плоскоклеточный. Ассоциация онкологов России, Ассоциация специалистов по проблемам меланомы, Российское общество клинической онкологии. Клинические рекомендации. Год утверждения: 2018.

http://www.oncology.ru/association/clinical-guidelines/2018/rak-kozhi-bazalnokletochnyj-i-ploskokletochnyj_pr2018.pdf [Basal cell and squamous cell carcinoma.[Russian Oncology Association, Russian melanoma professional association. Russian Society of Clinical Oncology. Clinicalguidelines. 2018 (InRuss.)].

Bichakjian C.K., Olencki T., Aasi S.Z. et al. Basal Cell Skin Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. J NatlComprCancNetw. 2016;14(5):574‐597. doi:10.6004/jnccn.2016.0065.

Молочков В.А., Молочков А.В. Клиническая дерматоонкология. М.: Из-во студия МДВ, 2011: 340 [Мolochkov V.A., Molochkov A.V. Clinical dermatooncology. Moscow: MDV Studio, 2011:340 (InRuss.)].

Дерматовенерология. Национальное руководство. Краткое издание / под ред. Ю. С. Бутова, Ю. К. Скрипкина, О. Л. Иванова. М. : ГЭОТАР-Медиа, 2013: 896 [Butova Y.S., Skripkina Y.K., Ivanova O.L., editors. Dermatology. National guidelines. M.:GEOTAR-Media,2013:896 (In Russ.)].

Шляхтунов Е.А., Гидранович А.В., Луд Н.Г. и др. Рак кожи: современное состояние проблемы. Вестник ВГМУ. 2014; 13(3):20-28 [Shlyahtunov E.A., Gidranovich A.V., Lud N.G. et al. Skin cancer: current state of the problem. Bulletin of Vitebsk state medical university. 2014;13(3):20-28 (in Russ.)].

Боулинг Д. Диагностическая дерматоскопия [Текст]: иллюстрированное руководство /под общ. ред. Кубановой А.А.; пер. с англ.: Романов Д.В. Москва, Изд-во Панфилова: Бином, 2013:145 [Bowling J. Diagnostic Dermoscopy. The Illustrated Guide / KubanovaАА, editor; transl. by Romanov DV. Moscow, Binom, 2013; 145 (in Russ.)].

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

© АННМО «Вопросы онкологии», Copyright (c) 2021